Evidence map›Paper›PMID 27525192›Full record

ArticleJournal of community medicine & health education2016

Building a Community - Academic Partnership to Enhance Hepatitis C Virus Screening.

R Irvin, A McAdams-Mahmoud, D Hickman, J Wilson, W Fenwick, I Chen, N Irvin, O Falade-Nwulia, M Sulkowski, R Chaisson and 2 more

Abstract read
In one paragraph

Article in Journal of community medicine & health education, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Reply to MacDonald et al.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  4. Article
  5. Article
  6. Article
  7. An Education and Field Experience Program to Increase Detection of Human Immunodeficiency Virus and Hepatitis C Virus.Progress in community health partnerships : research, education, and action · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

R IrvinDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
A McAdams-MahmoudDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
D HickmanSisters Together and Reaching, Incorporated, Baltimore, MD, USA.
J WilsonSisters Together and Reaching, Incorporated, Baltimore, MD, USA.
W FenwickSisters Together and Reaching, Incorporated, Baltimore, MD, USA.
I ChenDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
N IrvinDepartment of Emergency Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
O Falade-NwuliaDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
M SulkowskiDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
R ChaissonDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
D L ThomasDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
S H MehtaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
HIV HCV Coinfection Antiviral Therapy and FibrosisR37DA013806 · NIDA · JOHNS HOPKINS UNIVERSITY · PI THOMAS, DAVID L · 2010 to 2019
$7.0M
UCLA Implementation Science and Substance Use Research and Education (ISSURE) ProgramR25DA035692 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI TIMOTHY W FONG, GAIL E. WYATT · 2013 to 2026
$3.9M
Patient Oriented Research in Hepatitis C-infected Injection Drug UsersK24DA034621 · NIDA · JOHNS HOPKINS UNIVERSITY · PI SULKOWSKI, MARK SEBASTIAN · 2012 to 2022
$1.2M
NIAID NIH HHS P30 AI094189NIDA NIH HHS K24 DA034621NIDA NIH HHS R25 DA035692NIDA NIH HHS R37 DA013806
6 · The paper itself

Abstract

backgroundAn estimated 3.5 million Americans are chronically infected with hepatitis C virus (HCV). However, the majority are unaware of their HCV diagnosis and few are treated. New models are required to diagnose and link HCV infected patients to HCV care. This paper describes an innovative partnership between Sisters Together and Reaching (STAR), Inc., a community organization, and Johns Hopkins University (JHU), an academic institution, for the identification of HCV cases.

methodsSTAR and JHU identified a mutual interest in increasing hepatitis C screening efforts and launched an HCV screening program which was designed to enhance STAR's existing HIV efforts. STAR and JHU used the Bergen Model of Collaborative Functioning as theoretical framework for the partnership. We used descriptive statistics to characterize the study population and correlates of HCV antibody positivity were reported in univariable/multivariable logistic regression.

resultsFrom July 2014 to June 2015, 325 rapid HCV antibody tests were performed in community settings with 49 (15%) positive HCV antibody tests. 33 of the 49 HCV antibody positive individuals answered questions about their HCV testing history and 42% reported a prior positive result but were not engaged in care and 58% reported that they were unaware of their HCV status. In multivariable analysis, factors that were significantly associated with screening HCV antibody positive were increasing age (AOR: 1.06, 95% CI 1.02-1.10), male sex (AOR: 5.56, 95% CI 1.92-14.29), and history of injection drug use (AOR: 39.3, 95% CI 15.20-101.49).

conclusionsThe community-academic partnership was successful in identifying individuals with hepatitis C infection through a synergistic collaboration. The program data suggests that community screening may improve the hepatitis C care continuum by identifying individuals unaware of their HCV status or aware of their HCV status but not engaged in care and linking them to care.

Indexed as

Hepatitis C virusScreeningTesting

Identifiers

PMID27525192
PMCPMC4982512

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.